Conclusion
fracture
SECONDARY
The innovative Patient Pathway Pharmacist intervention was successfully implemented for nearly all patients in primary and secondary care settings. The intervention contributed to hip fracture patient safety through higher quality medication information in the discharge summary, lower number of PIMs, and higher proportion receiving standard pharmacotherapy. The intervention had no effect on the secondary outcomes readmission rate or mortality. Future studies are needed to explore the generalisability of this intervention.
